These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 8542594)

  • 21. Detection of overexpressed and phosphorylated wild-type kit receptor in surgical specimens of small cell lung cancer.
    Tamborini E; Bonadiman L; Negri T; Greco A; Staurengo S; Bidoli P; Pastorino U; Pierotti MA; Pilotti S
    Clin Cancer Res; 2004 Dec; 10(24):8214-9. PubMed ID: 15623596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin-like growth factor-I can mediate autocrine proliferation of human small cell lung cancer cell lines in vitro.
    Nakanishi Y; Mulshine JL; Kasprzyk PG; Natale RB; Maneckjee R; Avis I; Treston AM; Gazdar AF; Minna JD; Cuttitta F
    J Clin Invest; 1988 Jul; 82(1):354-9. PubMed ID: 2839551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implication of tyrosine kinase receptor and steel factor in cell density-dependent growth in cervical cancers and leukemias.
    Caceres-Cortes JR; Alvarado-Moreno JA; Waga K; Rangel-Corona R; Monroy-Garcia A; Rocha-Zavaleta L; Urdiales-Ramos J; Weiss-Steider B; Haman A; Hugo P; Brousseau R; Hoang T
    Cancer Res; 2001 Aug; 61(16):6281-9. PubMed ID: 11507083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The multi-targeted kinase inhibitor SU5416 inhibits small cell lung cancer growth and angiogenesis, in part by blocking Kit-mediated VEGF expression.
    Litz J; Sakuntala Warshamana-Greene G; Sulanke G; Lipson KE; Krystal GW
    Lung Cancer; 2004 Dec; 46(3):283-91. PubMed ID: 15541812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coexpression of the c-kit receptor and the stem cell factor in gynecological tumors.
    Inoue M; Kyo S; Fujita M; Enomoto T; Kondoh G
    Cancer Res; 1994 Jun; 54(11):3049-53. PubMed ID: 7514496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The insulin-like growth factor-I (IGF-I) receptor kinase inhibitor NVP-ADW742, in combination with STI571, delineates a spectrum of dependence of small cell lung cancer on IGF-I and stem cell factor signaling.
    Warshamana-Greene GS; Litz J; Buchdunger E; Hofmann F; García-Echeverría C; Krystal GW
    Mol Cancer Ther; 2004 May; 3(5):527-35. PubMed ID: 15141010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of cellular proliferation, cytoskeletal function, and signal transduction through CXCR4 and c-Kit in small cell lung cancer cells.
    Kijima T; Maulik G; Ma PC; Tibaldi EV; Turner RE; Rollins B; Sattler M; Johnson BE; Salgia R
    Cancer Res; 2002 Nov; 62(21):6304-11. PubMed ID: 12414661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stem cell factor/c-Kit interactions regulate human islet-epithelial cluster proliferation and differentiation.
    Li J; Goodyer CG; Fellows F; Wang R
    Int J Biochem Cell Biol; 2006; 38(5-6):961-72. PubMed ID: 16213778
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stem cell factor is not essential for cell survival and proliferation of soft tissue sarcoma of neuroectodermal origin.
    Ricotti E; Bertorello N; Vai S; Pagani A; Cordero Di Montezemolo L; Madon E; Basso G
    Haematologica; 1999 Oct; 84(10):879-86. PubMed ID: 10509034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of the decreased expression of alpha3beta1 integrin with the altered cell: environmental interactions and enhanced soft agar cloning ability of c-myc-overexpressing small cell lung cancer cells.
    Barr LF; Campbell SE; Bochner BS; Dang CV
    Cancer Res; 1998 Dec; 58(23):5537-45. PubMed ID: 9850091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enforced c-KIT expression renders highly metastatic human melanoma cells susceptible to stem cell factor-induced apoptosis and inhibits their tumorigenic and metastatic potential.
    Huang S; Luca M; Gutman M; McConkey DJ; Langley KE; Lyman SD; Bar-Eli M
    Oncogene; 1996 Dec; 13(11):2339-47. PubMed ID: 8957075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aberrant activation of c-kit protects colon carcinoma cells against apoptosis and enhances their invasive potential.
    Bellone G; Carbone A; Sibona N; Bosco O; Tibaudi D; Smirne C; Martone T; Gramigni C; Camandona M; Emanuelli G; Rodeck U
    Cancer Res; 2001 Mar; 61(5):2200-6. PubMed ID: 11280787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aberrant autophosphorylation of c-Kit receptor in canine mast cell tumor cell lines.
    Takeuchi Y; Fujino Y; Watanabe M; Nakagawa T; Ohno K; Sasaki N; Sugano S; Tsujimoto H
    Vet Immunol Immunopathol; 2010 Oct; 137(3-4):208-16. PubMed ID: 20591500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin 4 down-regulates expression of c-kit and autocrine stem cell factor in human colorectal carcinoma cells.
    Lahm H; Amstad P; Yilmaz A; Borbenyi Z; Wyniger J; Fischer JR; Suardet L; Givel JC; Odartchenko N
    Cell Growth Differ; 1995 Sep; 6(9):1111-8. PubMed ID: 8519688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of c-kit and stem cell factor mRNA in liver specimens from healthy adult dogs.
    Morimoto M; Tsujimura T; Kanakura Y; Kitamura Y; Matsuda H
    Am J Vet Res; 1998 Mar; 59(3):363-6. PubMed ID: 9522959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypoxia-inducible factor (HIF)-1 alpha directly enhances the transcriptional activity of stem cell factor (SCF) in response to hypoxia and epidermal growth factor (EGF).
    Han ZB; Ren H; Zhao H; Chi Y; Chen K; Zhou B; Liu YJ; Zhang L; Xu B; Liu B; Yang R; Han ZC
    Carcinogenesis; 2008 Oct; 29(10):1853-61. PubMed ID: 18339685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression and mutational status of c-kit in small-cell lung cancer: prognostic relevance.
    Boldrini L; Ursino S; Gisfredi S; Faviana P; Donati V; Camacci T; Lucchi M; Mussi A; Basolo F; Pingitore R; Fontanini G
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4101-8. PubMed ID: 15217946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Imatinib mesylate lacks activity in small cell lung carcinoma expressing c-kit protein: a phase II clinical trial.
    Krug LM; Crapanzano JP; Azzoli CG; Miller VA; Rizvi N; Gomez J; Kris MG; Pizzo B; Tyson L; Dunne M; Heelan RT
    Cancer; 2005 May; 103(10):2128-31. PubMed ID: 15812822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. M3 muscarinic receptor antagonists inhibit small cell lung carcinoma growth and mitogen-activated protein kinase phosphorylation induced by acetylcholine secretion.
    Song P; Sekhon HS; Lu A; Arredondo J; Sauer D; Gravett C; Mark GP; Grando SA; Spindel ER
    Cancer Res; 2007 Apr; 67(8):3936-44. PubMed ID: 17440109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression and mutational analysis of tyrosine kinase receptors c-kit, PDGFRalpha, and PDGFRbeta in ovarian cancers.
    Wilczynski SP; Chen YY; Chen W; Howell SB; Shively JE; Alberts DS
    Hum Pathol; 2005 Mar; 36(3):242-9. PubMed ID: 15791568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.